JAK: 2-methyl-1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine
JAK is a Ligand Of Interest in 4F09 designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4F09_JAK_A_1201 | 69% | 31% | 0.079 | 0.93 | 1.09 | 1.62 | 1 | 6 | 3 | 0 | 100% | 1 |
| 4EHZ_JAK_D_1201 | 95% | 19% | 0.039 | 0.979 | 0.85 | 2.49 | 1 | 8 | 0 | 0 | 100% | 1 |
